Manchester Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-329	Closed	-$26K	–	606
2019 Q1	$26K	Buy	+329	New	+$26K	﹤0.01%	490
2015 Q1	–	Sell	-7,173	Closed	-$238K	–	721
2014 Q4	$238K	Buy	+7,173	New	+$238K	0.03%	323